The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2018 | Quality of life in cutaneous lymphoma patients: patient-reported outcomes
Pablo Ortiz Romero, MD, PhD, of the University Hospital 12 of October, Madrid, Spain, speaks at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland, on the quality of life of patients with cutaneous T-cell lymphoma. Prof. Ortiz expresses his concerns about clinical outcomes and patient expectations as a doctor, and highlights the need to gather more information on patient-reported outcomes to support the decision-making process of doctors.
